The Global Non‑Opioid Pain Treatment Market is witnessing rapid transformation as healthcare stakeholders increasingly focus on safer, effective alternatives to traditional opioid therapies. Driven by rising patient awareness, technological advancements, and growing healthcare expenditures, the market is projected to reach USD 85.6 billion by 2031 , registering a CAGR of 7.4% during...